Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine Distemper Virus Matrix Protein (M), N-His

Cat. No.VG3F210

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Canine Distemper Virus Matrix Protein (M), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 39.9 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli Expression System
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 39.9 kDa
Physical State Lyophilized
Formulation PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

The Matrix (M) protein is a central structural component of CDV, acting as the "bridge" between the inner ribonucleoprotein (RNP) and the outer viral envelope. It orchestrates viral assembly and budding by interacting with the cytoplasmic tails of the H and F glycoproteins and the RNP complex. M protein drives the formation of virus-like particles (VLPs) and regulates viral RNA synthesis. Its ability to associate with the host plasma membrane is crucial for virion egress and overall viral pathogenicity, making it a key target for antiviral drug development.

Protein Canine Distemper Virus Matrix Protein (M)
Protein Synonym CDV-M; Matrix protein; M protein; Membrane-associated protein M; Morbillivirus matrix protein
UniProt ID P06943

Shipping and Storage

This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket